Balyasny Asset Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,323
Closed -$142K 3297
2022
Q1
$142K Buy
+1,323
New +$207K ﹤0.01% 2086

Other funds holding SNCE

Balyasny Asset Management's SNCE Position: Q2 2022 in Review

Balyasny Asset Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q2 2022, closing a stake of 1,323 shares — an estimated $142K sold.

Balyasny Asset Management first reported a position in SNCE in Q1 2022 and held it in 1 quarter. The position peaked at $142K in Q1 2022. 76 funds tracked by Wall St. Rank hold SNCE as of Q2 2022.

  • Balyasny Asset Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 1,323 Science 37 Holdings, Inc. Common Stock shares in Q2 2022, an estimated $142K.
  • Balyasny Asset Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Balyasny Asset Management's Science 37 Holdings, Inc. Common Stock position peaked at $142K in Q1 2022.
  • 76 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q2 2022.

Based on Balyasny Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.